Johnson Johnson Stock Performance
| JNJ Stock | USD 162.81 0.18 0.11% |
Johnson Johnson has a performance score of 13 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.11, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Johnson Johnson's returns are expected to increase less than the market. However, during the bear market, the loss of holding Johnson Johnson is expected to be smaller as well. Johnson Johnson right now retains a risk of 1.14%. Please check out Johnson Johnson potential upside, and the relationship between the total risk alpha and kurtosis , to decide if Johnson Johnson will be following its current trending patterns.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Johnson Johnson are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Even with relatively abnormal basic indicators, Johnson Johnson may actually be approaching a critical reversion point that can send shares even higher in April 2025. ...more
Actual Historical Performance (%)
One Day Return 0.3 | Five Day Return (0.26) | Year To Date Return 13.39 | Ten Year Return 63.48 | All Time Return 13.3 K |
Forward Dividend Yield 0.0305 | Payout Ratio | Last Split Factor 2:1 | Forward Dividend Rate 4.96 | Dividend Date 2025-03-04 |
1 | Insider Trading | 01/10/2025 |
2 | Disposition of 1007 shares by Kristen Mulholland of Johnson Johnson subject to Rule 16b-3 | 02/14/2025 |
3 | Tevogen Bio Founder and CEO Dr. Ryan Saadi Named to 2025 NJBIZ Power 100, Celebrating Innovation and Leadership in Accessible T Cell Therapy | 02/28/2025 |
| Johnson Johnson dividend paid on 4th of March 2025 | 03/04/2025 |
4 | Johnson Johnson to Host Investor Conference Call on First-Quarter Results | 03/05/2025 |
5 | How pharmaceutical companies are training their workers on AI | 03/10/2025 |
6 | Johnson Johnson Reports Positive Phase 2b Trial Results For Ulcerative Colitis Treatment | 03/11/2025 |
7 | STEQEYMA , a biosimilar to STELARA , now available in the United States | 03/12/2025 |
8 | ISRG Stock Price Falls to 200-DMA Should You Buy, Hold or Sell | 03/13/2025 |
9 | Johnson Johnson Could Be a Great Choice | 03/14/2025 |
| Begin Period Cash Flow | 21.9 B |
Johnson |
Johnson Johnson Relative Risk vs. Return Landscape
If you would invest 14,525 in Johnson Johnson on December 17, 2024 and sell it today you would earn a total of 1,756 from holding Johnson Johnson or generate 12.09% return on investment over 90 days. Johnson Johnson is generating 0.1936% of daily returns assuming volatility of 1.1351% on return distribution over 90 days investment horizon. In other words, 10% of stocks are less volatile than Johnson, and above 97% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Johnson Johnson Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Johnson Johnson's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Johnson Johnson, and traders can use it to determine the average amount a Johnson Johnson's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1705
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | JNJ | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.14 actual daily | 10 90% of assets are more volatile |
Expected Return
| 0.19 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average Johnson Johnson is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Johnson Johnson by adding it to a well-diversified portfolio.
Johnson Johnson Fundamentals Growth
Johnson Stock prices reflect investors' perceptions of the future prospects and financial health of Johnson Johnson, and Johnson Johnson fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Johnson Stock performance.
| Return On Equity | 0.2 | ||||
| Return On Asset | 0.0813 | ||||
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.18 % | ||||
| Current Valuation | 404.46 B | ||||
| Shares Outstanding | 2.41 B | ||||
| Price To Earning | 24.69 X | ||||
| Price To Book | 5.49 X | ||||
| Price To Sales | 4.42 X | ||||
| Revenue | 88.82 B | ||||
| Gross Profit | 61.79 B | ||||
| EBITDA | 24.78 B | ||||
| Net Income | 14.07 B | ||||
| Cash And Equivalents | 5.37 B | ||||
| Cash Per Share | 13.03 X | ||||
| Total Debt | 36.63 B | ||||
| Debt To Equity | 0.43 % | ||||
| Current Ratio | 1.43 X | ||||
| Book Value Per Share | 29.70 X | ||||
| Cash Flow From Operations | 24.27 B | ||||
| Earnings Per Share | 5.80 X | ||||
| Market Capitalization | 392.35 B | ||||
| Total Asset | 180.1 B | ||||
| Retained Earnings | 153.84 B | ||||
| Working Capital | 5.57 B | ||||
| Current Asset | 60.21 B | ||||
| Current Liabilities | 27.75 B | ||||
About Johnson Johnson Performance
By evaluating Johnson Johnson's fundamental ratios, stakeholders can gain valuable insights into Johnson Johnson's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Johnson Johnson has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Johnson Johnson has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 176.75 | 149.35 | |
| Return On Tangible Assets | 0.33 | 0.34 | |
| Return On Capital Employed | 0.22 | 0.25 | |
| Return On Assets | 0.24 | 0.13 | |
| Return On Equity | 0.46 | 0.48 |
Things to note about Johnson Johnson performance evaluation
Checking the ongoing alerts about Johnson Johnson for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Johnson Johnson help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 74.0% of the company shares are owned by institutional investors | |
| On 4th of March 2025 Johnson Johnson paid $ 1.24 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: Johnson Johnson Could Be a Great Choice |
- Analyzing Johnson Johnson's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Johnson Johnson's stock is overvalued or undervalued compared to its peers.
- Examining Johnson Johnson's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Johnson Johnson's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Johnson Johnson's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Johnson Johnson's stock. These opinions can provide insight into Johnson Johnson's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Johnson Johnson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Johnson Stock please use our How to buy in Johnson Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Johnson Johnson. If investors know Johnson will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Johnson Johnson listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.03) | Dividend Share 4.91 | Earnings Share 5.8 | Revenue Per Share | Quarterly Revenue Growth 0.053 |
The market value of Johnson Johnson is measured differently than its book value, which is the value of Johnson that is recorded on the company's balance sheet. Investors also form their own opinion of Johnson Johnson's value that differs from its market value or its book value, called intrinsic value, which is Johnson Johnson's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Johnson Johnson's market value can be influenced by many factors that don't directly affect Johnson Johnson's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Johnson Johnson's value and its price as these two are different measures arrived at by different means. Investors typically determine if Johnson Johnson is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Johnson Johnson's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.